iShares Micro-Cap ETF
The fund invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 3Y SHOWN · NET +$49M OVER THIS RANGE
Money keeps arriving — +$11M of net buying over the past month, about 0.7% of the fund's asset base, while the price has returned +25.5% so far this year. At 0.60% a year it is not the cheapest way in — IBRN runs the same ground at 0.47%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS TODAY’S MOVE · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | PENGPenguin Solutions | 0.71% | $53.64 | -8.1% | ||
| 2 | NRIXNURIX THERAPEUTICS | 0.58% | $27.88 | +3.7% | ||
| 3 | SLSSELLAS LIFE SCIENCES GROUP | 0.55% | $13.81 | +5.4% | ||
| 4 | OUSTOUSTER | 0.68% | $40.53 | -6.2% | ||
| 5 | CDNACAREDX | 0.53% | $46.70 | +1.3% | ||
| 6 | TILEINTERFACE | 0.50% | $38.92 | +0.5% | ||
| 7 | VRDNVIRIDIAN THERAPEUTICS | 0.47% | $24.65 | +3.2% | ||
| 8 | URGNUROGEN PHARMA | 0.47% | $50.21 | +2.3% | ||
| 9 | MBXMBX Biosciences | 0.47% | $67.44 | +2.0% | ||
| 10 | INODINNODATA | 0.46% | $63.49 | +2.3% | ||
| 11 | BFLYBUTTERFLY NETWORK | 0.43% | $9.03 | +0.3% | ||
| 12 | NUVBNUVATION BIO | 0.37% | $7.34 | +5.8% | ||
| 13 | QCRHQCR HOLDINGS | 0.39% | $104.17 | -0.6% | ||
| 14 | EFCELLINGTON FINANCIAL | 0.38% | $13.68 | +0.4% | ||
| 15 | PRCHPORCH GROUP | 0.37% | $17.14 | +2.9% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 1473| 1 week | +0.3% |
| 1 month | +3.9% |
| 3 months | +11.5% |
| 6 months | +19.9% |
| YTD | +25.5% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$16M |
| 1 month | +$11M |
| 3 months | +$31M |
| YTD | +$141M |
| 1 year | +$211M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 0.7% of the book; the top ten carry 5%. Spread across 250+ names, it behaves like roughly 205 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| SLS SELLAS LIFE SCIENCES GROUP | $11M | $4M |
| PURR Hyperliquid Strategies | $5M | $3M |
| ASST ASSET ENTITIES | $2M | $2M |
| PGEN PRECIGEN | $2M | $2M |
| ZVRA ZEVRA THERAPEUTICS | $2M | $2M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat IWC on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $128.4B | +$547M | -55bp on fee · 84× the assets · +$547M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.7B | +$104M | -56bp on fee · 21× the assets · +$104M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.4B | +$520M | -56bp on fee · 15× the assets · +$520M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.7B | +$312M | -56bp on fee · 12× the assets · +$312M in over the month | Head-to-head |
| IEFA iShares Core MSCI EAFE ETF | 0.07% | $195.3B | +$631M | -53bp on fee · 128× the assets · +$631M in over the month | Head-to-head |